Suppr超能文献

英格兰和威尔士育龄妇女中B19细小病毒感染的负担。

The burden of parvovirus B19 infection in women of childbearing age in England and Wales.

作者信息

Vyse A J, Andrews N J, Hesketh L M, Pebody R

机构信息

Health Protection Agency, Centre for Infections, Sero-Epidemiology Unit, Immunisation Department, London, UK.

出版信息

Epidemiol Infect. 2007 Nov;135(8):1354-62. doi: 10.1017/S0950268807007856. Epub 2007 Feb 12.

Abstract

A serological survey has been used to investigate the epidemiology of parvovirus B19 infection in England and Wales. A total of 2835 sera representing the complete age range were selected from a convenience collection obtained in 1996 that reflects the general population and screened for parvovirus B19-specific IgG. Antibody prevalence rose nonlinearly with age from 21% in those aged 1-4 years to >75% in adults aged > or = 45 years. Force-of-infection estimates were similar to those previously made in 1991, being highest in those aged <15 years. There was no association between evidence of previous infection and sex or region. Quantitatively strongest antibody responses were found in those aged 15-34 years and IgG levels in females were 28.5% higher than those found in males (P=0.004, 95% CI 8.2-52.6). Applying the upper 95% confidence interval for the force of infection to maternity estimates for England and Wales in 1996, parvovirus infection in pregnancy was estimated to occur on average in up to 1 in every 512 pregnancies each year. This represents 1257 maternal infections, causing up to an estimated 59 fetal deaths and 11 cases of hydrops fetalis annually. An analysis of all available laboratory-confirmed parvovirus infections found a mean of 944 infections per year in women aged 15-44 years highlighting a need for enhanced surveillance of maternal parvovirus B19 infection in England and Wales, including information on both pregnancy and outcome of pregnancy.

摘要

一项血清学调查被用于研究英格兰和威尔士细小病毒B19感染的流行病学情况。从1996年获取的一组能代表全年龄段的2835份血清样本中进行便利抽样,这些样本反映了普通人群的情况,并对其进行细小病毒B19特异性IgG筛查。抗体流行率随年龄呈非线性上升,从1 - 4岁人群中的21%升至45岁及以上成年人中的>75%。感染强度估计与1991年之前的结果相似,在15岁以下人群中最高。既往感染证据与性别或地区之间无关联。在15 - 34岁人群中发现了定量上最强的抗体反应,女性的IgG水平比男性高28.5%(P = 0.004,95%置信区间8.2 - 52.6)。将感染强度的95%置信区间上限应用于1996年英格兰和威尔士的孕产妇感染估计,估计每年每512例妊娠中平均有1例发生细小病毒感染。这意味着每年有1257例孕产妇感染,估计导致多达59例胎儿死亡和11例胎儿水肿。对所有可用的实验室确诊的细小病毒感染进行分析发现,15 - 44岁女性每年平均有944例感染,这凸显了在英格兰和威尔士加强对孕产妇细小病毒B19感染监测的必要性,包括妊娠及妊娠结局相关信息。

相似文献

1
The burden of parvovirus B19 infection in women of childbearing age in England and Wales.
Epidemiol Infect. 2007 Nov;135(8):1354-62. doi: 10.1017/S0950268807007856. Epub 2007 Feb 12.
3
The burden of infection with cytomegalovirus in England and Wales: how many women are infected in pregnancy?
Epidemiol Infect. 2009 Apr;137(4):526-33. doi: 10.1017/S0950268808001258. Epub 2008 Sep 15.
4
Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):46-9. doi: 10.1016/j.ejogrb.2005.11.042. Epub 2006 Jan 6.
6
Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection.
Epidemiol Infect. 2008 Aug;136(8):1059-68. doi: 10.1017/S0950268807009661. Epub 2007 Oct 24.
7
Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany.
Epidemiol Infect. 2007 May;135(4):563-9. doi: 10.1017/S095026880600731X. Epub 2006 Oct 26.
10
[Antibodies against human parvovirus B19 in the Madrid community].
Enferm Infecc Microbiol Clin. 1999 Aug-Sep;17(7):364-5.

引用本文的文献

3
Efficient Neutralizing Antibodies Induction by Human Parvovirus B19 Epitope-Presenting Protein Nanoparticles.
Microbiol Immunol. 2025 Jan;69(1):35-42. doi: 10.1111/1348-0421.13182. Epub 2024 Nov 15.
4
Prenatal parvovirus B19 infection.
Arch Gynecol Obstet. 2024 Nov;310(5):2363-2371. doi: 10.1007/s00404-024-07644-6. Epub 2024 Jul 29.
6
Parvovirus B19 in Croatia: A Large-Scale Seroprevalence Study.
Medicina (Kaunas). 2021 Nov 21;57(11):1279. doi: 10.3390/medicina57111279.
9
Inferring influenza infection attack rate from seroprevalence data.
PLoS Pathog. 2014 Apr 3;10(4):e1004054. doi: 10.1371/journal.ppat.1004054. eCollection 2014 Apr.
10
Estimating the risk of parvovirus B19 infection in blood donors and pregnant women in Japan.
PLoS One. 2014 Mar 21;9(3):e92519. doi: 10.1371/journal.pone.0092519. eCollection 2014.

本文引用的文献

2
Parvovirus B19 viraemia in Dutch blood donors.
Epidemiol Infect. 2004 Dec;132(6):1161-6. doi: 10.1017/s0950268804002730.
3
Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults.
Epidemiol Infect. 2004 Dec;132(6):1129-34. doi: 10.1017/s0950268804003140.
8
Immediate and long term outcome of human parvovirus B19 infection in pregnancy.
Br J Obstet Gynaecol. 1998 Feb;105(2):174-8. doi: 10.1111/j.1471-0528.1998.tb10048.x.
9
Analysis of serological surveys using mixture models: application to a survey of parvovirus B19.
Stat Med. 1996 Jul 30;15(14):1567-73. doi: 10.1002/(SICI)1097-0258(19960730)15:14<1567::AID-SIM289>3.0.CO;2-G.
10
Female children respond to recombinant hepatitis B vaccine with a higher titre than male.
J Trop Pediatr. 1994 Apr;40(2):104-7. doi: 10.1093/tropej/40.2.104.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验